Ooni Koda
  1. Home
  2. /
  3. Newsfeed
  4. /
  5. Agreement between Nuclearelectrica and Framatome for the production...

Agreement between Nuclearelectrica and Framatome for the production in Romania of the radioisotope Lutetium-177 used in the fight against cancer

January 4, 2024

SN Nuclearelectrica SA and Framatome have announced the signing of a cooperation agreement to explore the possibility of producing the medical isotope Lutetium – 177 in the Cernavoda nuclear-electrical unit. Lutetium – 177 is used for a variety of treatment for cancer.According to a press release of SN Nuclearelectrica, the initial domain of implementation of the agreement includes a technical feasibility study, based on the Framatome production technology for isotopes, successfully implemented in Canada in 2022.Framatome and Nuclearelectrica will work together to analyse how to maximize the existing infrastructure in Cernavoda in order to produce medical isotopes, besides the clean, safe, reliable, carbon emissions-free energy generated at present.‘In the light of recent evolutions on the market of medical isotopes, the need for safe supply with medical isotopes is growing and, as a result, we consider that this is the right moment to develop projects of medical isotopes production at CNE Cernavoda’ said Cosmin Ghita, CEO Nuclearelectrica.In his turn, Francois Gauche, the manager of Framatome Healthcare stated: ‘We are delighted to have this project with Nuclearelectrica. Mass access to nuclear medicine is closely connected to the development of supply chains on a large scale, reliable and diversified and we want to play a role in the fight against cancer, by helping to the construction of these supply chains. In order to better help the patients in the future, we will need regional nuclear medicine production centres and this project is an excellent opportunity to consolidate the supply chain in Europe’.Nuclearelectrica has 27 years of experience in safe exploitation of the nuclear-electrical unit in CNE Cernavoda, being considered one of the most performing companies in the domain, at global level. Through strategic investment projects (Retechnologisation of Unit1 CNE Cernavoda, development of Unit 3 and 4 CNE Cernavoda, development of SMR project, development of Detritiation Facility) the company wants to supply clean energy, to support the objectives of energy stability and decarbonisation of Romania, to support the Paris Agreement and on the basis of ESG strategy to support the initiatives with impact on human health, similar to this agreement.Framatome Healthcare commits to develop products and services for the health industry. The team supports the value chain of the radioisotopes used in the radiopharmaceuticals for diagnostic imaging and for therapeutical purposes, supplies advanced solutions for complex installations for sterilization, essential for the use of medical materials. The Framatome Healthcare experts promote fight against cancer, develop and support medical apps of the nuclear technology.  

Read in full - click here
RWEA, RPIA and PATRES Warn: The Abrupt Implementation of the New Grid Connection Methodology Will Block the Connection Process

The Romanian Wind Energy Association (RWEA), the Romanian Photovoltaic Industry Association (RPIA) and the Renewable Energy Producers Organization in Romania (PATRES), representing members with a total installed capacity of over 6.5 GW, warn of the risk of a major bottleneck in the energy sector caused by the introduction, without a transition period and with an […]

Romania attracts massive Turkish investments in green energy. Storage projects, the new trend

Romania is emerging as one of the most dynamic markets for Turkish renewable energy investments, attracting growing interest from industrial and financial groups with regional exposure. Real grid connection opportunities for viable projects, infrastructure modernization potential, and investment framework stability make Romania a strategic destination for Turkish capital, at a time when Europe is accelerating […]

Romanian feature film CATANE nominated at Hollywood Music in Media Awards

CATANE, the feature debut of director Ioana Mischie, has received an international nomination at the prestigious Hollywood Music in Media Awards for its original score composed by Emiliano Mazzenga. The film’s music has been selected among the top five film scores worldwide in the International Independent Film category.  The film is the first Romanian production ever […]

Moldovan prime minister Alexandru Munteanu makes first official visit to Bucharest, meets PM and president

Moldovan prime minister Alexandru Munteanu arrived in Bucharest on Thursday, November 13, for his first official foreign visit since taking office. He met with president Nicușor Dan and Romanian counterpart Ilie Bolojan before visiting the Parliament, where he met with the president of the Senate, Mihai Abrudean. After the first meeting, president Nicușor Dan stated […]

Cushman & Wakefield Echinox report reveals consistent office pipeline in Bucharest

Bucharest maintains a steady flow of new office developments, with nearly 170,000 square meters of projects scheduled for delivery between 2026 and 2027, according to the latest Bucharest Office Marketbeat Q3 2025 report from Cushman & Wakefield Echinox. Despite a 25% drop in total leasing activity compared to last year, demand remained solid, with companies […]

eJobs reports steep decline in Romanians seeking work abroad

The number of Romanians seeking work abroad has fallen to its lowest level in five years, according to new data from leading online recruitment platform eJobs. So far in 2025, only 106,000 applications were submitted for jobs outside Romania out of a total of 9.8 million, representing just 1.1% of all job applications.  Employers abroad […]